GAMCO INVESTORS, INC. ET AL - WUXI PHARMATECH CAYMAN INC ownership

WUXI PHARMATECH CAYMAN INC's ticker is WX and the CUSIP is 929352102. A total of 154 filers reported holding WUXI PHARMATECH CAYMAN INC in Q2 2015. The put-call ratio across all filers is 3.79 and the average weighting 0.4%.

Quarter-by-quarter ownership
GAMCO INVESTORS, INC. ET AL ownership history of WUXI PHARMATECH CAYMAN INC
ValueSharesWeighting
Q3 2015$2,649,000
+15.7%
61,300
+13.1%
0.02%
+41.7%
Q2 2015$2,290,000
+3.2%
54,200
-5.2%
0.01%0.0%
Q1 2015$2,218,000
+15.2%
57,2000.0%0.01%
+20.0%
Q4 2014$1,926,000
-3.8%
57,2000.0%0.01%
-9.1%
Q3 2014$2,003,000
+6.5%
57,2000.0%0.01%
+10.0%
Q2 2014$1,880,000
-14.6%
57,200
-4.2%
0.01%
-16.7%
Q1 2014$2,201,000
-12.0%
59,700
-8.4%
0.01%
-7.7%
Q4 2013$2,502,000
+5.4%
65,200
-24.7%
0.01%
-7.1%
Q3 2013$2,373,000
-3.5%
86,600
-26.0%
0.01%
-6.7%
Q2 2013$2,459,000117,1000.02%
Other shareholders
WUXI PHARMATECH CAYMAN INC shareholders Q2 2015
NameSharesValueWeighting ↓
PSquared Asset Management AG 171,495$7,410,00032.67%
Newport Asia LLC 714,600$30,877,00012.95%
Coupland Cardiff Asset Management LLP 45,000$1,944,0006.29%
NINE MASTS CAPITAL Ltd 525,985$22,730,0005.83%
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC 2,694,589$116,433,0005.17%
PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC 220,131$9,512,0004.79%
Sensato Investors LLC 549,341$23,737,0004.44%
Grandeur Peak Global Advisors, LLC 396,743$17,143,0003.83%
Taconic Capital Advisors LP 2,150,000$92,902,0003.43%
Central Asset Investments & Management Holdings (HK) Ltd 68,815$2,973,0003.26%
View complete list of WUXI PHARMATECH CAYMAN INC shareholders